Davies M J, Dysart R H, Silbert B S, Scott D A, Cook R J
Department of Anaesthesia, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Anaesth Intensive Care. 1992 May;20(2):161-4. doi: 10.1177/0310057X9202000207.
A double-blind, randomised, controlled trial of forty patients was carried out to determine if oral atenolol pretreatment would reduce the incidence of tachycardia during carotid endarterectomy performed under cervical plexus block. Twenty patients received a placebo and twenty patients 50 mg of atenolol two hours prior to surgery. The superficial and deep cervical blocks were performed with 1.5% lignocaine containing 1:200,000 adrenaline. The patients were monitored with the V5 lead of the electrocardiogram and intra-arterial blood pressure. These measurements were recorded on a correctly calibrated paper recorder. Tachycardia (heart rate greater than 90 beats per minute for more than three minutes) occurred in thirteen patients in the placebo group and two patients in the atenolol group (P less than 0.01). There was no difference in the occurrence of bradycardia, hypotension or hypertension between the two groups. It is concluded that atenolol pretreatment is an effective method of reducing the incidence of tachycardia during carotid endarterectomy performed under cervical plexus blockade.
进行了一项针对40名患者的双盲、随机对照试验,以确定口服阿替洛尔预处理是否会降低在颈丛阻滞下行颈动脉内膜切除术时心动过速的发生率。20名患者接受安慰剂,20名患者在手术前两小时服用50毫克阿替洛尔。使用含1:200,000肾上腺素的1.5%利多卡因进行颈浅丛和深丛阻滞。通过心电图V5导联和动脉内血压对患者进行监测。这些测量值记录在经过正确校准的纸带记录仪上。安慰剂组有13名患者出现心动过速(心率大于90次/分钟持续超过三分钟),阿替洛尔组有2名患者出现心动过速(P<0.01)。两组之间心动过缓、低血压或高血压的发生率没有差异。得出的结论是,阿替洛尔预处理是降低在颈丛阻滞下行颈动脉内膜切除术时心动过速发生率的有效方法。